Real‐life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1‐year follow‐up data report

BACKGROUND: Progressive supranuclear palsy (PSP) is a progressive neurodegenerative condition presenting with different clinical endophenotypes. The parkinsonian variant of PSP (PSP‐P) is characterised by early but fading responsiveness to high‐dose levodopa therapy; however, high‐dose oral therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Metta, Vinod, Chaudhuri, K. Ray, Leta, Valentina, Mridula, Kandadai Rukmini, Koduri, Chaitanya, Deepak, Sai, Kalpala, Rakesh, Reddy, Nageswar, Chung‐Faye, Guy, Borgohain, Rupam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480946/
https://www.ncbi.nlm.nih.gov/pubmed/35943202
http://dx.doi.org/10.1002/brb3.2547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9480946/
https://www.ncbi.nlm.nih.gov/pubmed/35943202
http://dx.doi.org/10.1002/brb3.2547

Ejemplares similares